{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "TWD", "exchange": "TWO", "shortName": "Gongwin", "longName": "Gongwin Biopharm Holdings Co., Ltd.", "messageBoardId": "finmb_413701845", "exchangeTimezoneName": "Asia/Taipei", "exchangeTimezoneShortName": "CST", "gmtOffSetMilliseconds": 28800000, "market": "tw_market", "esgPopulated": false, "regularMarketChangePercent": -1.8487396, "regularMarketPrice": 292.0, "marketState": "POSTPOST", "firstTradeDateMilliseconds": 1486515600000, "priceHint": 2, "epsTrailingTwelveMonths": -2.26, "sharesOutstanding": 113089000, "bookValue": 8.429, "fiftyDayAverage": 309.52, "fiftyDayAverageChange": -17.519989, "fiftyDayAverageChangePercent": -0.05660374, "twoHundredDayAverage": 348.90445, "twoHundredDayAverageChange": -56.90445, "twoHundredDayAverageChangePercent": -0.16309465, "marketCap": 33246535680, "priceToBook": 34.642307, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "tradeable": false, "cryptoTradeable": false, "regularMarketChange": -5.5, "regularMarketTime": 1684133998, "regularMarketDayHigh": 297.5, "regularMarketDayRange": "285.5 - 297.5", "regularMarketDayLow": 285.5, "regularMarketVolume": 68437, "regularMarketPreviousClose": 297.5, "bid": 285.5, "ask": 291.5, "bidSize": 0, "askSize": 0, "fullExchangeName": "Taipei Exchange", "financialCurrency": "TWD", "regularMarketOpen": 297.5, "averageDailyVolume3Month": 117868, "averageDailyVolume10Day": 163531, "fiftyTwoWeekLowChange": 51.5, "fiftyTwoWeekLowChangePercent": 0.21413721, "fiftyTwoWeekRange": "240.5 - 457.0", "fiftyTwoWeekHighChange": -165.0, "fiftyTwoWeekHighChangePercent": -0.36105034, "fiftyTwoWeekLow": 240.5, "fiftyTwoWeekHigh": 457.0, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "symbol": "6617.TWO"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "No. 80, Jianguo North Road", "address2": "3rd Floor Section 1 Zhongshan District", "city": "Taipei", "zip": "104", "country": "Taiwan", "phone": "886 2 2503 5282", "website": "https://www.gongwinbiopharm.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Gongwin Biopharm Holdings Co., Ltd., a clinical-stage biopharmaceutical company, develops anticancer drugs. It is developing PTS302, which has completed Phase III clinical trials for the treatment of lung cancer; PTS100, which is in Phase II clinical trials for the treatment of liver cancer; PTS-02 for the treatment of adenoid cystic carcinoma; and PTS500 for the treatment of malignant pleural effusion. The company was founded in 2014 and is based in Taipei, Taiwan.", "companyOfficers": [{"maxAge": 1, "name": "Lester  Wu", "title": "Founder & Chairman", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Yuan Lin  Mao", "title": "Gen. Mang.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Rocky  Shih", "title": "Co-Founder", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Nan Hu  Wei", "title": "CFO & Head of Admin. Division", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Guillaume  Danecki", "title": "Sr. Director of Bus.& Market Division", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}